Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.580
-0.130-2.28%
Volume:35.27M
Turnover:195.82M
Market Cap:104.25B
PE:36.74
High:5.630
Open:5.605
Low:5.440
Close:5.710
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.58
T/O Rate:0.19%
Dividend:0.12
Dividend Rate:2.15%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.74
PE(LYR):36.74
PS:2.64

Loading ...

Sino Biopharm Wins NMPA Nod to Start LM-364 Nectin-4 TME ADC Trial in Solid Tumors

Reuters
·
Aug 28

Sino Biopharmaceutical - Lm-364 'Nectin-4Tme ADC' Receives Nmpa Clinical Trial Approval for Advanced Solid Tumors

THOMSON REUTERS
·
Aug 28

Movement Alert|SBP GROUP Falls 3.05% in Regular Trading, Trading at HK$5.545

Market Focus
·
Aug 27

China's Innovative Weight-Loss Patch Receives US Clinical Trial Approval

Deep News
·
Aug 26

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 26

Movement Alert|SBP GROUP Rises 3.29% in Regular Trading, GLP-1 Weight Management Microneedle Patch Receives US FDA Clinical Trial Approval

Market Focus
·
Aug 26

Sino Biopharma Wins FDA Clearance to Start Trial of Cpx301 GLP-1 Weight-Loss Microneedle Patch

Reuters
·
Aug 25

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.67 From HK$8.26, Keeps at Buy

MT Newswires Live
·
Aug 24

Sino Biopharmaceutical (SEHK:1177) Could Be 66% Below Fair Value As Earnings Lift Interest

Simply Wall St.
·
Aug 22

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

SBP Group's Novel Weight Management Therapy Gains Regulatory Nod for Clinical Trials

Stock News
·
Aug 21

Sino Biopharm Says NMPA Clears Tqf6422 Obesity Drug Candidate for Clinical Trial

Reuters
·
Aug 21

Sino Biopharmaceutical - Application for Clinical Trial on Tqf6422 Injection "Actrii a/B Monoclonal Antibody" Approved by Nmpa

THOMSON REUTERS
·
Aug 21

Movement Alert|SBP GROUP Rises 3.15% in Regular Trading, Continued Post-Earnings Momentum Supported by Analyst Upgrades

Market Focus
·
Aug 21

Sino Biopharmaceutical (SEHK:1177) Stock Faces Margin Strain Despite Profit Recovery

Simply Wall St.
·
Aug 21

China's 3SBio H1 Net Profit Falls on Higher Expenses

Reuters
·
Aug 20

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Reuters
·
Aug 20

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat

Stock News
·
Aug 20